Thought leading ideas and opinion
Citeline's expert analysts regularly produce reports on key aspects of the industry, new therapy developments and trends. Enjoy free access to these insights by downloading our latest whitepapers below.
A Tale of Two CETPs
Citeline's Senior Director of Cardiovascular and Metabolic/Endocrinology, Gail Parziale, looks at CETP inhibitors in the treatment of Cardiovascular disease, summarizing the progress made by Merck and Roche.
Download Citeline Pharma R&D Annual Review 2011
In comparison with 2010 trends, Citeline’s Annual Review has identified flat growth of the overall R&D pipeline in 2011, but a 13% growth in drugs at Phase III status.
Download Biosimilar mAbs in the Pipeline
Senior Analyst in Oncology, Fern Barkalow, takes a look at the development of biosimilars for monoclonal antibodies, reviewing major players, strategies, regional guidelines and future developments.
Download